PLSEPulse Biosciences, Inc.

$1B

Q1 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$12M

Net Income

-$12M

EPS (Diluted)

$-0.57

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$32M

Total Liabilities

$10M

Stockholders' Equity

$22M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$167,000	+100.0%
Operating Income	-$12M	-$10M	-14.8%
Net Income	-$12M	-$10M	-17.8%

PLSE Q1 2020 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena